Literature DB >> 886967

[Use of acetylsalicylic acid in the prevention of re-occlusion following revascularization interventions. Results of a double-blind long term study].

U Ehresmann, J Alemany, D Loew.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 886967

Source DB:  PubMed          Journal:  Med Welt        ISSN： 0025-8512


× No keyword cloud information.
  7 in total

1.  Graft material and results of platelet inhibitor trials in peripheral arterial reconstructions: reappraisal of results from a meta-analysis.

Authors:  H R Watson; A M Skene; G Belcher
Journal:  Br J Clin Pharmacol       Date:  2000-05       Impact factor: 4.335

Review 2.  Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-15

3.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

Review 4.  The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials.

Authors:  P J Roderick; H C Wilkes; T W Meade
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

Review 5.  Antiplatelet drugs: clinical pharmacology and therapeutic use.

Authors:  A S Gallus
Journal:  Drugs       Date:  1979-12       Impact factor: 9.546

Review 6.  Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.

Authors:  Rachel Bedenis; Anne Lethaby; Heather Maxwell; Stefan Acosta; Martin H Prins
Journal:  Cochrane Database Syst Rev       Date:  2015-02-19

7.  Efficacy and safety of aspirin in patients with peripheral vascular disease: An updated systematic review and meta-analysis of randomized controlled trials.

Authors:  Ahmed N Mahmoud; Akram Y Elgendy; Cecil Rambarat; Dhruv Mahtta; Islam Y Elgendy; Anthony A Bavry
Journal:  PLoS One       Date:  2017-04-12       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.